Morbid obesity leads to increased skin autofluorescence independent of metabolic syndrome components

Creative Commons License

APAYDIN T., YAVUZ D.

TURKISH JOURNAL OF MEDICAL SCIENCES, vol.52, no.4, pp.1085-1092, 2022 (SCI-Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 52 Issue: 4
  • Publication Date: 2022
  • Doi Number: 10.55730/1300-0144.5411
  • Journal Name: TURKISH JOURNAL OF MEDICAL SCIENCES
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.1085-1092
  • Keywords: Advanced glycation end products, metabolic syndrome, morbid obesity, skin autofluorescence, GLYCATION END-PRODUCTS, BARIATRIC SURGERY, ENDOTHELIAL DYSFUNCTION, NONINVASIVE MARKER, ENDPRODUCTS, MORTALITY, RISK
  • Open Archive Collection: AVESIS Open Access Collection
  • Marmara University Affiliated: Yes

Abstract

Background/aim: Obesity, diabetes mellitus, and metabolic syndrome (MetS) are associated with increased accumulated skin advanced glycation end products. We aimed to evaluate the association of MetS components with skin autofluorescence (SAF) in patients with morbid obesity.